Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid to Offer HIV, HCV Testing Under Amended License Deal with Applera

NEW YORK, June 29 (GenomeWeb News) - Cepheid and Applera have amended a license agreement between the companies to allow Cepheid to sell two of its real-time thermal cyclers to detect, characterize, and monitor HIV and hepatitis C infections, the companies said today.


"Although further licenses may be required to introduce clinical tests for quantitative detection of HIV and Hepatitis C, this first step removes a significant impediment to the development of those tests," said John Bishop, Cepheid CEO, in a statement.


The amended license agreement affects both Cepheid's SmartCycler and its GeneXpert platforms.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.